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Abstract
Background: Few studies have examined seizures in pediatric brain arteriovenous malformation. In our study, risk
factors associated with seizure occurrence and long-term seizure control outcomes after different treatments in
pediatric arteriovenous malformation patients were investigated.
Methods: A retrospective analysis was conducted with clinical data from a cohort of 89 pediatric brain
arteriovenous malformation patients acquired between 2008 and 2013. Univariate and multivariate analyses were
used to assess risk factors associated with seizure incidence. Patients who presented with seizure before treatment
were evaluated using the Engel classification during the follow-up period.
Results: A higher risk of seizure occurrence was observed in large size and unruptured brain arteriovenous
malformations using multivariate logistic regression analysis (p < 0.05). A total of 22 children, who presented with
seizure before the interventions, were included in subsequent analysis. During a mean follow-up period of 2.3 years
after the intervention, 12 (55 %) of these children were classified as Engel class I after treatment.
Conclusions: Seizures were the most common symptom in unruptured bAVMs. Size of the brain arteriovenous
malformation is highly significant to seizure occurrence. Patients with cerebral hemorrhage are prone to having an
acute seizure occurrence. The different therapies examined all improved seizure control to varying degrees.
Background
Brain arteriovenous malformations (bAVMs) are con-
genital vascular lesions. Patients with bAVMs usually
become symptomatic at age 20–40 and typically present
with hemorrhage, seizure, or local neurological deficits.
Treatment options include microsurgery, radiosurgery,
embolization, or a combination of these, with the goal of
therapy being complete resection or obliteration of the
bAVMs. Treatment reduces the risk of bAVM-related
intracranial hemorrhage (ICH) in patients with a history
of hemorrhage.
Pediatric bAVMs account for approximately 3–19 %
of all bAVMs [1] and are thought to have different
clinical, radiological, and outcome characteristics compared
to adult bAVMs. Children with bAVMs have a higher
annual risk of hemorrhage than adults with bAVMs
(2–4 % vs.1–3 % per year) [2], and in around 25 % of
these children, hemorrhage is fatal. Because of the
high overall lifetime risk of bleeding, an aggressive
treatment approach is justified in children with unrup-
tured bAVMs.
Seizures are the second most common initial mani-
festation in children with bAVMs and can affect their
intellectual capacity and neuropsychological status,
among other deleterious effects [3]. Though prevention
of bleeding rather than seizure control is the primary
reason for considering surgery in pediatric patients
with unruptured bAVMs, seizure occurrence and its
post-operative outcome deserve consideration. Seizure
control rate is low in patients with unruptured bAVMs
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bAVM surgery. Additionally, surgery can raise the risk
of seizure in patients with ruptured bAVMs [5–8].
The current literature has primarily focused on bAVM-
related hemorrhage or seizure in adult cohorts. So far, lit-
tle is known about the incidence and outcomes of seizure
in pediatric bAVMs. In this study, we summarize our
experience with the treatment of a serial cohort of 89
pediatric bAVMs. We focus on their long-term seizure
control outcomes after different treatments and identify
the factors associated with pre-therapy seizure incidence.
Methods
Patient population
We retrospectively reviewed all children aged up to
18 years who were admitted with cerebrovascular dis-
eases to our department of neurosurgery at the West
China hospital in China between March 2008 and
December 2013. The inclusion criteria were defined as
ruptured or unruptured intracranial AVM diagnosed by
digital subtraction angiography before the intervention
therapy. We excluded cavernous malformation, dural
and pial arteriovenous fistulas, and vein malformations.
Eighty-nine children were identified consecutively
(Fig. 1). The following information was collected during
review of the medical records: age, sex, clinical pre-
sentations, neurological signs at admission, history of
intracranial hemorrhage, hemorrhage broken into the
ventricle (IVH), the DSA finding, the treatment mo-
dality, seizure type, duration of seizure, seizure fre-
quency, and seizure outcome after treatment. History
of intracranial hemorrhage was defined as the patient
having presented with hemorrhage in their patient
history. The DSA finding included the nidus location,
size, involvement of the eloquent area, and the
Spetzler-Martin grade [9].
Clinical outcome was assessed via the regular out-
patient and telephone interview. We also made a special
follow-up telephone call to identify each child’s recent
status. In all the patients for whom we received follow-
up information, DSA/CT angiography was generally
performed 1–3 months after the microsurgery or the
embolization. Adjuvant therapy was sometimes per-
formed when a patient presented with a residual lesion.
Seizure assessment
During long-term follow-up, seizure outcomes were
determined using the modified Engel Classification scale
[10]. Class I was defined as seizure free, auras only, or
seizures upon drug withdrawal only; Class II as a 90 %
reduction in seizure frequency or a single post-operative
seizure; Class III as a 50 % reduction in seizure
frequency or no change in seizure frequency; and Class
IV as an increase in postoperative seizure frequency.
Patients were defined as having new-onset seizure when
they developed epilepsy after their bAVMs treatment,
during the follow-up period. These new-onset seizure
patients were excluded from further analysis of seizure
control outcome. We defined the duration of seizure as
time between first seizure onset and the treatment.
Treatment modalities
Pediatric bAVMs cases were referred to our department
from other hospitals in the Sichuan province (population
of 80 million). Except in cases requiring emergency ICH
evacuation, for small bAVMs (size < 3 cm) or intermedi-
ate bAVMs (size ≥ 3 cm and size ≤ 6 cm), we sought to
Fig. 1 Distribution of the patients selected in our study
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excise the nidus through open microsurgery. For large
bAVMs (size > 6 cm), we performed endovascular treat-
ment followed by partial or complete obliteration of
the nidus to achieve flow reduction and partial nidus
obliteration. When complete obliteration was unlikely,
we performed additional stereotactic radiosurgery or
microsurgery. In our center, microsurgery was usually
considered the first-choice treatment and Stealth intra-
operative neuronavigation was usually used to assist
localization. However, radiosurgery was considered in
some cases in which bAVMs were difficult to access
surgically or in which operative risk was high. All ra-
diosurgery patients were treated with the Leksell
Gamma Knife model C (Elekta, Sweden) using existing
planning software.
When a patient underwent multimodality AVM treat-
ment, we classified them in the microsurgery group if
they underwent microsurgery, in the embolization group
if they did not undergo microsurgery (irrespective of
whether they received stereotactic radiosurgery or not),
and in the radiosurgery group if they only underwent
this therapy.
Patients with a history of seizure generally received an-
tiepileptic drugs (AEDs) before the therapy. During the
microsurgery and embolization, sodium valproate was
administered intravenously and tapered post-operatively
over 3 days, after which oral AEDs were administered.
The oral outpatient AEDs most commonly used was le-
vetiracetam or oxcarbazepine, which were administered
according to the child’s weight. Patients were tapered off
AEDs when they remained seizure-free for 3 months
after the intervention. Patients or their relatives gave
informed consent for participation in the study, as well
as for the publication of their clinical details. The ethical
approval for this study, including retrospective data col-
lection, was granted by the Biological and Medical Ethics
Committee of West China Hospital.
Statistical analysis
We analyzed children’s sex, age, admission Glasgow
coma scale (GCS) score, ICH, IVH, bAVM size, venous
drainage, eloquent area, location, and Spetzler-Martin
grade to determine whether these factors were associ-
ated with preoperative seizure occurrence. The chi-
squared test was used for categorical variables (e.g., sex)
and Student’s t-test was used for continuous variables
(e.g., age). For further analysis of preoperative factors as-
sociated with seizures, significant factors from univariate
analyses were entered into a multivariate logistic regres-
sion. All statistical analyses were 2-tailed (α = 0.05), and
a p-value of ≤0.05 was considered statistically significant.
Statistical analyses were performed using SPSS version
21.0 (IBM Corporation, Armonk, NY, USA).
Results
Study population
The study group consisted of 89 children of whom 52
were boys (58.4 %) and 37 were girls (41.6 %). The mean
age was 12.2 years (range 1–18 years). In these 89 patients,
2 patients refused the subsequent intervention therapy in
our hospital when they finished their DSA examinations.
For the remaining 87 patients, mean follow-up duration
was 1.8 years (ranging from immediately following treat-
ment to 68 months). 3 patients eventually discontinued
follow-up treatment after having undergone it for at least
7 months.
According to the Glasgow outcome scale (GOS), a
good recovery was achieved in 82 out of the remaining
87 patients (95.4 %) and only 3 patients were moderately
disabled (3.4 %). The mortality rate was 2.3 % (n = 2).
These two patients underwent open-operation therapy
to evacuate the hemorrhage and AVM nidus. One pa-
tient death was related to the pre-operative deep comatose
state of the patient, while the other patient died of brain
infection and hydrocephalus after the surgery.
Among the patients, 45 (50.6 %) presented with head-
ache, 24 (27.0 %) with seizures, 12 (13.5 %) with neuro-
logical deficits, and 3 (3.4 %) were asymptomatic. 67
(75.3 %) children sustained intracranial hemorrhage due
to bAVMs. The initial clinical manifestations when they
were admitted to the hospital included abrupt headache
(n = 38), disturbance of consciousness (n = 13), focal
neurological deficits (n = 10), seizure (n = 5) and dizziness
(n = 1). Of the 3 asymptomatic patients, 1was found to
present with bAVMs in an MRI scan that was being con-
ducted because of short stature, 1 was found after a minor
car accident, and 1 had fever and headache and was diag-
nosed with viral encephalitis. For the latter patient, the le-
sion was found during a follow-up brain CT examination.
The patient’s clinical presentation disappeared when his
encephalitis was cured. The clinical and angioarchitectural
features of the 89 patients are summarized in Table 1.
During the follow-up period, 5 (5.7 %) of the 87 patients
exhibited rebleeding. Of these, 3 had previously undergone
only radiosurgery as an initial therapy. After the recurrent
hemorrhage, one of these three patients underwent micro-
surgery and subsequent radiosurgery therapy, while the
other two patients underwent embolization and radiosur-
gery therapy. Their last postoperative angiograms showed
obliteration rates of 90 % (patient 1 in Table 2), 80 and
90 %, respectively. Of the other 2 patients that exhibited
rebleeding, one had undergone an initial therapy of
embolization and subsequent radiosurgery, while the other
patient had undergone an initial therapy of only
embolization. After rebleeding, the two patients under-
went microsurgery and embolization along with radiosur-
gery, respectively. Their latest DSA examinations showed
no residual AVMs.
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Table 1 Factors associated with seizure occurrence in the 89 pediatric brain arteriovenous malformation patients
Factors Group No seizure Seizure P value
Univariate Multivariate
Sex Male 35 17 0.149
Female 30 7
Age Mean ± SD 12.11 ± 3.554 12.25 ± 3.814 0.870
Admission GCS score ≤8 11 4 0.837
9–12 5 1
≥13 49 19
ICH Yes 56 11 0.000 0.007
No 9 13
IVH Yes 24 5 0.151
No 41 19
Size Small 43 4 0.000 0.005
Medium 16 14
Large 6 6
Venous drainage Deep 40 8 0.030 0.305
Superficial 22 12
Mixed 3 4
Eloquent area Yes 23 6 0.354
No 42 18








Thalamus/basal Ganglia 14 1
Spetzler-Martin grade Grade 1 13 1 0.090
Grade 2 21 10
Grade 3 22 7
Grade 4 8 3
Grade 5 1 3
ICH Intracerebral hemorrhage, GCS Glasgow coma scale, IVH Hemorrhage broken into the ventricle












1 Microsurgery 3th days CP levetiracetam 2 in the first
month
2 1 month DSA- after the
surgery
2 Embolization <24 hours GTC lamotrigine and
levetiracetam
monthly 11 10 months DSA-
3 Embolization <24 hours SP oxcarbazepine 3 in 1 year 10 3 years 80 %
4 Radiosurgery 7th days CP levetiracetam 4 in 1 year 10 3 years 90 %
GTC Generalized tonicoclonic seizure, ABS Absence seizure, SP Simple seizure, CP Complex seizure, DSA- Digital substract angiography negative
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Factors associated with seizure occurrence
In the univariate analysis, factors not significantly associ-
ated with seizure included sex (χ2 = 2.082, p = 0.149), age
(p = 0.870), admission GCS score (χ2 = 0.357, p = 0.837),
IVH (χ2 = 2.066, p = 0.151), eloquent area (χ2 = 0.860, p =
0.354), location (χ2 = 13.949, p = 0.083) and Spetzler-Martin
grade (χ2 = 8.039, p = 0.090). There were 3 features sig-
nificantly associated with initial seizure presentation: size
(χ2 = 17.273, p = 0.000), hemorrhage (χ2 = 15.313, p = 0.000),
and venous drainage (χ2 = 7.019, p = 0.030). After multi-
variate analysis, only larger size (OR = 3.063, 95 % CI =
1.414–6.634, p = 0.005) and hemorrhage (OR = 0.196,
95 % CI = 0.060–0.640, p = 0.007) remained significantly
associated with initial seizure presentation (Table 1).
Hemorrhage and seizure outcome
There were 67 (75.3 %) patients that presented with
hemorrhage, 29 of who presented with hemorrhage
broken into the ventricle. 15 patients with intracerebral
hemorrhage (22.4 %) reported acute symptomatic seizures.
Of these, 11 (16.4 %) had seizures before the intervention
therapy, and 10 were included in further analysis of seiz-
ure outcome. In the long-term follow-up, 6 of these 10
patients achieved Engel class I, 2 patients achieved Engel
class II, and 2 patients achieved Engel class III. Neither of
the 2 class III patients showed complete obliteration of
bAVMs at the last imaging examination of the follow-up.
In contrast, among the 22 unruptured bAVMs patients, as
many as 13 presented with seizure and of these 13, 12
were included in further analysis of seizure outcomes. In
the long-term follow-up, 6 of these patients were Engel
class I and the other 6 were Engel class II.
A total of 4 patients developed new-onset seizure after
the therapy and all of them presented with hemorrhage.
Of these, 2 patients had undergone embolization therapy,
while the remaining 2 were treated with microsurgery and
radiosurgery, respectively (Table 2). The median number
of days to seizure post-therapy was 3 (range 1–7). Neither
of the two embolization patients had seizures before treat-
ment, but both had seizures immediately post-therapy
(<24 h). One of the embolization patients received a sec-
ond embolization and subsequent radiosurgery 6 months
after the initial embolization therapy. His seizures disap-
peared 4 months after the second therapy. The other
embolization patient received a second embolization and
AED therapy (patient 3 in Table 2), but still experienced
occasional seizures. The seizures ceased after the patient
underwent radiosurgery approximately 3 years later, while
the complete obliteration of the nidus was still not
achieved at that time (patient 4 in Table 2).
Seizure type/duration and seizure outcome
There were a total of 24 patients who had seizures occur
before therapy. One patient who refused subsequent
intervention therapy and one patient who died after the
surgery were excluded from further analysis of seizure
outcome. Of the remaining 22 children with seizure, the
mean follow-up time was 2.3 years (range 12–60
months). There were 12 (55 %) Engel Class I patients,
8 (36 %) Engel Class II patients, and 2 (9 %) Engel Class
III patients. Most children experienced generalized toni-
coclonic seizures (64 %), whereas others experienced
absence (4 %), simple partial (18 %), or complex partial
(14 %) seizures. Engel class I was achieved by 3 of 4 (75 %)
patients that presented simple seizures, 1 (100 %) patient
that presented absence seizure and 8 of 14 (57 %) patients
that presented generalized tonic-clonic seizures. All 3 pa-
tients that presented complex seizures were classified as
Engel class II.
Of the patients who had seizures before therapy, 8 of
them had presented seizures for longer than 6 months.
2 patients still had monthly seizure occurrences upon
receiving combined AEDs therapy before the interven-
tion. After intervention therapy, the DSA examinations
for both patients were negative for the presence of
bAVMs. However, both patients still presented seizures
and were classified as Engel Class II. 10 of 14 (71 %)
patients with seizure duration of less than 6 months
achieved Engel Class I, while only 2 of 8 (25 %) patients
with seizure duration longer than 6 months achieved
Class I (Additional file 1: Table S1). 5 of the 8 patients
with longer seizure durations had negative DSA results.
Therapy modality and seizure outcome
Nine of 22 patients were treated with microsurgery, 3 pa-
tients with embolization, and 1 patient with radiosurgery.
In addition, 2 patients underwent embolization prior to
AVM resection, 1 patient underwent microsurgery and
subsequent radiosurgery, and 6 patients underwent com-
bined embolization and radiosurgery. The mean follow-up
time in embolization group (n = 10) and microsurgery
group (n = 11) were 23.4 and 28.8 months, respectively.
Six of 10 (60 %) patients in the embolization group and 5
of 11 (45 %) patients in the microsurgery group achieved
Engel class I. The patient who underwent radiosurgery
alone was seizure free without requiring AEDs at follow-
up. By the last follow-up, 13 patients had achieved
complete obliteration of the nidus. Among them, 8 pa-
tients achieved Engel class I, and the remaining 5 patients
achieved Engel class II.
Discussion
Seizure is the second most common symptom of
bAVMs following hemorrhage, with up to 40 % of
bAVMs patients presenting with seizures [11, 12]. Even
when the bAVMs nidus is obliterated or removed
through microsurgery, radiosurgery, or embolization,
many patients still suffer from seizures that can affect
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their quality of life [5, 8, 12, 13]. In our study, out of 89
children with bAVMs, 67 (75.3 %) had hemorrhaged and
24 (27.0 %) had experienced seizures before therapy. In
the long-term follow-up to these seizure patients, 12
(55 %) achieved an Engel class I status after the therapy,
with a mean follow-up period of 2.3 years.
The mechanisms by which bAVMs lead to epilepto-
genesis remain unclear, although many studies have
identified significant risk factors for epilepsy [7, 14, 15].
Hol et al. studied clinical predictors of seizure incidence
and seizure outcomes in bAVMs patients with seizure
and observed that male sex, age less than 65 years,
bAVMs size greater than 3 cm, and bAVMs location in
the temporal lobe are associated with pretreatment
seizure [16]. Shankar et al. analyzed angioarchitectural
characteristics of unruptured bAVMs in a consecutive
series of patients presenting with seizures and proposed
that venous outflow stenosis, long pial draining vein
and location of bAVMs are the strongest predictors of
seizures [17]. A recent prospective study investigating
seizures as the initial presentation of bAVMs found
that predisposing factors include male sex, increasing
bAVMs size, superficial venous drainage, and location
in the frontal lobe and arterial border-zone [18].
In our study, we found that only size and hemorrhage
were significant factors associated with seizure occur-
rence in pediatric bAVMs, while age, gender, and other
factors were unrelated to seizure occurrence. Previous
studies have shown an association between larger
bAVMs sizes and greater seizure incidence [8, 17, 19].
bAVM size may affect the occurrence of seizures by cre-
ating a hypoxic environment in surrounding brain tissue,
a condition known to lead to seizures. Larger bAVMs
tended to have more arteriovenous shunting of blood, a
factor associated with focal cerebral ischemia [17].
We found that hemorrhage is another significant fac-
tor correlated with seizure, consistent with findings
from a number of previous studies. The products of
blood metabolism, such as hemosiderin, can cause focal
cerebral irritation, which may lead to seizure. This has
been shown in animal models of focal epilepsy pro-
duced by iron deposition on the brain cortex [20].
However, in our study, as many as 13 of 22 patients
with unruptured bAVMs (i.e., without bleeding) pre-
sented with seizures. The finding that seizure occurrence
in unruptured bAVMs is significantly higher than that in
the hemorrhage group (59 % vs.16 %) is somewhat para-
doxical given that we found hemorrhage is a significant
factor correlated with seizure. A plausible interpretation is
that many bAVMs are not detected unless they become
symptomatic e.g., when they present with seizures or when
they rupture. As such, in unruptured bAVMs initially
identified because of seizures, prompt therapy is taken to
avoid hemorrhage [21]. Consistent with this, seizures were
the most common symptom in unruptured bAVMs. In a
previous report, seizure risk was highest during the first
24 h after hemorrhagic stroke and tended to decrease
thereafter [20]. The majority of our patients developed
acute symptomatic seizures in the early stage of
hemorrhage, before therapy. This finding supports an epi-
leptogenic role of blood evacuation. However, it is worth
noting that patients with new-onset seizure after the ther-
apy all had a history of hemorrhage. Seizure occurrence in
cortical regions may be a complication of invasive micro-
surgery. Moreover, the residual hemorrhage, the partial
obliteration of lesion, and the sudden change in
hemodynamic upon embolism therapy may also con-
tribute to seizure onset. In the long-term follow-up, the
non-hemorrhage group had a slightly better seizure
control rate compared to the hemorrhage group. How-
ever, considering the limited patient number in the
study, it is difficult to draw any definitive conclusion
on the influence of hemorrhage on long-term seizure
control outcome. It remains unclear whether evacu-
ation of the hemorrhage could lead to better seizure
control than embolization and radiosurgery.
It has been suggested that pre-operative seizure type
and duration are prognostic factors for post-operative
seizure control. Hol et al. found that shorter seizure
duration and generalized tonicoclonic seizure type are
associated with good seizure outcomes [16]. Our data
showed 14 of 22 pediatric patients had generalized
tonicoclonic seizures and 8 of them (57 %) achieved
Engel Class I after the therapy. This seizure control rate
was lower than that for patients with simple seizures,
but better than that for patients with complex seizures.
In our series, the longer the duration of seizure, the
more likely the preoperative seizure was to belong term
repetitive and refractory. Only 25 % of our pediatric
patients with seizure histories longer than 6 months
were seizure-free post-operatively, but up to 71 % of
patients with shorter seizure histories were seizure-free.
To achieve a more favorable seizure outcome after sur-
gery for those patients with long duration and frequent
seizures, we advise a more aggressive surgical resection,
including the excision of cortical lining of AVMs, which
can exhibit hemosiderin deposits, gliosis, neuronal deg-
radation, or demyelization [3, 22].
Recently, Baranoski et al. compared seizure control
rates upon treatment of bAVMs with different thera-
peutic modalities and concluded that microsurgical
resection of bAVMs led to higher rates of seizure-free
patients and better seizure control than radiosurgery or
embolization [6, 23]. This may be attributable to the
presence of an epileptogenic focus at the site of the
bAVMs, as suggested by the presence of gliosis and
hemosiderin borders, which are considered epileptogenic
[4, 21].
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There have been few studies about the relationship
between seizure and embolization of bAVMs in adults or
children. One possible reason for this may be that
embolization therapy was once primarily used as a con-
junction therapy with microsurgery or radiosurgery [7, 8].
Of the 30 patients in a study by Lv X et al., 4 patients that
underwent complete embolization of their bAVMs
achieved excellent seizure control [8]. In our study, though
the mean obliteration rate was 90 %, 60 % of patients that
underwent embolization therapy achieved Engel class I.
However, both of the embolization patients had new-onset
seizures immediately after the procedure. Kede los also
reported that following embolization with the liquid em-
bolic agent Onyx, seizure occurred in 45 % (n = 9) of 20
patients and that the median time to seizure post-Onyx
was 7 days (range 0.3–210). The development of edema
and inflammation surrounding the nidus following Onyx
administration may play a role, especially in patients with
partial obliteration of bAVMs [7, 22].
Radiosurgery can eventually achieve a higher post-
operative seizure-free rate than microsurgery when the
lesion is completely obliterated [6, 24]. However, 2–3
years may be required to fully obliterate the lesion, and
patients risk the possibility of hemorrhage. Meanwhile,
some studies report that radiosurgery can affect epilep-
togenesis from tissue surrounding the bAVMs in a man-
ner independent of radiation-induced thrombosis of
bAVMs, and can reduce seizures even before complete
obliteration of bAVMs [16]. This is further evidenced by
our study, as one of the new-onset seizure patients who
underwent radiosurgery had seizures cease before the
nidus was fully obliterated.
The decision to surgically treat potentially epileptogenic
unruptured bAVMs is still a subject of controversy. Even
with AED therapy, seizure response remains variable for
these patients. Some people become drug resistant or
undergo refractory seizures and need an intervention ther-
apy in order to control their seizures. Most studies have
reported that microsurgery has a good seizure control
rate and can decrease the rate of spontaneous
hemorrhage [23, 24]. However, in a recent prospective,
population-based observational study, Josephson et al.
found no significant difference in the 5-year risk of
seizure in adults between the conservative and treat-
ment groups, irrespective of whether the bAVMs had
presented with hemorrhage or epileptic seizures [4].
One possible explanation for these results is that their
patients who underwent treatment for bAVMs may
have had a higher baseline propensity for seizures, and
that their seizures may have been refractory to conser-
vative care, thus resulting in bAVMs treatment [23, 24].
In our serial cohort, patients with unruptured bAVMs
have had varying degrees of improvement in control of
their seizures. Seizure-free states were achieved in 60 %
of patients in the embolization group, 45 % of those in
the surgery group, and 100 % of those in the radiosur-
gery group. Given that children have long life spans,
seizure can greatly impact their life and bring unex-
pected risk. We suggest active intervention treatment
to reduce the risk of hemorrhage and improve seizure
control, especially for medical management of refrac-
tory seizures. For some post-therapy refractory seizures,
we would consider epilepsy surgery to settle the seizure
or to remove the epileptic focus. Individual treatment
strategies should be made based on the presentation
and angio-architectural characteristics of the bAVM to
determine the optimal treatment modality.
Our study has several limitations. First, our study was
a retrospective analysis, and therefore, was subject to
biases inherent to that study design. Bias in the assess-
ment of patient seizures and in selection of patients for
different therapeutic modalities certainly influenced
our results. Second, the number of patients may not be
large enough to draw definitive conclusions regarding
treatment modality and the influence of hemorrhage on
long-term seizure control. Additionally, study of the re-
lationship between obliteration rate and seizure control
outcome requires a large sample size and a prospective
trial. Future work is required to reach a more definitive
conclusion.
Conclusion
Our study demonstrates seizure remains the most com-
mon symptom in unruptured bAVMs pediatric patients
and most children present with generalized seizures.
Size of the brain arteriovenous malformation is highly
significant to seizure occurrence. Patients with cerebral
hemorrhage are prone to having an acute seizure oc-
currence. Radiosurgery, embolization, and microsurgery
could all influence seizure control and reduce the risk
of rebleeding in pediatric bAVMs patients. What the
best therapy for seizure control in unruptured bAVMs
is remains a subject of debate. Moreover, considering
the young age at presentation, a careful follow-up is
needed to prevent future bAVMs and seizure recur-
rence in pediatric bAVMs patients.
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Additional file 1: Table S1. Characteristics and seizure outcomes of the
22 pediatric brain arteriovenous malformation patients. EVE, endovascular
embolization; MS, microsurgery; SRS, stereotactic radiosurgery; NA, not
clear. 18*: This patient underwent the combination of EVE and SRS as an
initial therapy and postoperative angiograms showed obliteration rates
of about 60 %. When he exhibited rebleeding, MS therapy was taken,
and post-operation DSA examination showed no residual bAVM.
(DOCX 18 kb)
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